Methodology
FISH
Test Description and clinical significance
Probes
RET (10q11.21)
Disease:
Non-small cell lung cancer, Papillary thyroid carcinoma
It is designed to detect chromosomal rearrangements involving the RET proto-oncogene (10q11.21). This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. The RET proto-oncogene encodes a tyrosine kinase receptor and under normal conditions, it functions as a signaling molecule involved in cellular growth and differentiation. Chromosomal rearrangements involving RET were identified in papillary thyroid carcinoma and Non-Small-Cell Lung Cancer (NSCLC) patients
Specimen Requirements
Collection:
FFPET/un-stained slides
Stability:
Indefinitely
Unacceptable Conditions:
Unlabeled specimen/Decalcified tissue/Insuffcient tissue fixation
Storage & Transport
Room Temperature
CPT(s)
88377
New York Approved
YES
TAT
3 Days
*The CPT codes provided are for informational purposes only and are based on AMA guidelines The billing party is solely responsible for correct CPT coding.
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.